|Application:||Gene expression microarray analysis|
|Number of samples:||24|
|Release date:||Mar 20 2013|
|Last update date:||Apr 11 2014|
|Diseases:||Carcinoma, Craniocerebral Trauma, Neoplasms, Tumor Lysis Syndrome|
|Dataset link||Tobacco smoking transcriptional imprinting contributes to urothelial cancer|
Gene expression profiling using GeneChip HG-U133A Plus 2.0 (Affymetrix) was performed on non-malignant and carcinogenic urothelium from six patients with superficial and six with invasive urothelial carcinoma, each group including two current, former, and non-smokers.